ARMO BioSciences' Series B Round

ARMO BioSciences raised a round of funding on May 28, 2014.

ARMO BioSciences is focused on developing immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis and inflammatory diseases. ARMO believes that by harnessing the bo…

Articles about ARMO BioSciences' Series B Round: